Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Chemical & Pharmaceutical Bulletin
|
May 1, 2022
Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines
Taro Shimizu, Yoshino Kawaguchi, Hidenori Ando, et al.
Biological & Pharmaceutical Bulletin
|
July 5, 2022
Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in Vitro
Yoshino Kawaguchi, Taro Shimizu, Hidenori Ando, et al.
International Journal of Pharmaceutics
|
January 9, 2025
An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivo
Yoshino Kawaguchi, Taro Shimizu, Haruka Takata, et al.
Journal of Pharmaceutical Sciences
|
February 1, 2025
A spleen-targeted vaccine for SARS-CoV-2 - Inducting neutralizing antibodies in mice
Taro Shimizu, Shunji Abe, Yoshino Kawaguchi, et al.
Biological & Pharmaceutical Bulletin
|
June 3, 2021
Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes
Hidenori Ando, Sherif E Emam, Yoshino Kawaguchi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 8, 2025
Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle
Shunji Abe, Haruka Takata, Taro Shimizu, et al.
International Journal of Pharmaceutics
|
March 30, 2021
Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies
Haruka Takata, Taro Shimizu, Yoshino Kawaguchi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 20, 2020
Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes
Taro Shimizu, Mizuki Awata, Amr S Abu Lila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 22, 2026
Inflammatory mediators of mRNA vaccine-induced adverse reactions in mice
Koyo Honda, Tatsuya Karaki, Yuta Kunishima, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 6, 2021
Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice
Sherif E Emam, Nehal E Elsadek, Amr S Abu Lila, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Chemical & Pharmaceutical Bulletin
|
May 1, 2022
Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines
Taro Shimizu, Yoshino Kawaguchi, Hidenori Ando, et al.
Biological & Pharmaceutical Bulletin
|
July 5, 2022
Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in Vitro
Yoshino Kawaguchi, Taro Shimizu, Hidenori Ando, et al.
International Journal of Pharmaceutics
|
January 9, 2025
An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivo
Yoshino Kawaguchi, Taro Shimizu, Haruka Takata, et al.
Journal of Pharmaceutical Sciences
|
February 1, 2025
A spleen-targeted vaccine for SARS-CoV-2 - Inducting neutralizing antibodies in mice
Taro Shimizu, Shunji Abe, Yoshino Kawaguchi, et al.
Biological & Pharmaceutical Bulletin
|
June 3, 2021
Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes
Hidenori Ando, Sherif E Emam, Yoshino Kawaguchi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 8, 2025
Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle
Shunji Abe, Haruka Takata, Taro Shimizu, et al.
International Journal of Pharmaceutics
|
March 30, 2021
Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies
Haruka Takata, Taro Shimizu, Yoshino Kawaguchi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 20, 2020
Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes
Taro Shimizu, Mizuki Awata, Amr S Abu Lila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 22, 2026
Inflammatory mediators of mRNA vaccine-induced adverse reactions in mice
Koyo Honda, Tatsuya Karaki, Yuta Kunishima, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 6, 2021
Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice
Sherif E Emam, Nehal E Elsadek, Amr S Abu Lila, et al.
Page
of 2